Clinical Study to Test the Efficacy and Safety of Adapalene, 0.1%

PHASE3CompletedINTERVENTIONAL
Enrollment

1,067

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

November 30, 2008

Study Completion Date

December 31, 2008

Conditions
Acne Vulgaris
Interventions
DRUG

Adapalene lotion 0.1%

Adapalene, 0.1% will be applied topically to the face, once a day, for 12 weeks

DRUG

Adapalene Lotion Vehicle

Vehicle will be applied topically to the face, once a day, for 12 weeks

Trial Locations (34)

10021

Fran Cook-Bolden, New York

14623

Dermatology Associates of Rochester, Rochester

27599

University of North Carolina at Chapel Hill, Chapel Hill

27612

Wake Research Associates, LLC, Raleigh

29464

Palmetto Medical Research, Mt. Pleasant

32174

Advanced Dermatology and Cosmetic Surgery, Ormond Beach

33781

Dermatology Research, Pinellas Park

37203

Dermatology Research Associates, Nashville

37215

Tennessee Clinical Research Center, Nashville

37917

Dermatology Associates, Knoxville

40202

Dermatology Specialists, Louisville

45219

University Dermatology Consultants, Cincinnati

48038

Midwest Cutaneous Research, Clinton Township

48202

Henry Ford Medical Center-Dept. of Dermatology, Detroit

55432

Minnesota Clinical Study Centert, Fridley

61820

Christie Clinic, PC, Champaign

66061

Compliant Clinical Research, Olathe

68144

Skin Specialists, PC, Omaha

73069

Central Sooner Research, Norman

77056

The Center for Skin Research, Houston

77802

J&S Studies, Inc., Bryan

80246

Cherry Creek Dermatology, Denver

84124

Dermatology Research Center, Salt Lake City

89511

Cindy Lamerson, Reno

92083

Dermatology Specialists, Inc., Vista

92123

University of California, San Diego

97210

Northwest Cutaneous Research Specialists, Portland

99204

Premier Clinical Research, Spokane

01830

East Coast Clinical Research, Inc., Haverhill

T3A 2N1

Dermatology Associates, Calgary

V5Z 3Y1

Derm Research @ 888 Inc, Vancouver

L4M 6L2

Ultranova Skincare, Barrie

P1B 3Z7

North Bay Dermatology Centre, North Bay

H3G 1C6

Siena Medical Research, Montreal

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Galderma R&D

INDUSTRY

NCT00599521 - Clinical Study to Test the Efficacy and Safety of Adapalene, 0.1% | Biotech Hunter | Biotech Hunter